APG Workstream Position Papers
A third of the world's population – about two billion people – do not have access to essential healthcare services and medicine; many of them live in low income countries. There are a number of issues that affect global access to medicines in which the APG plays an active role.
Those main issues include:
- Infrastructure in the developing world
- Differential Pricing
- Registration of Medicines in Africa
- Intellectual Property Rights and Patent Protection
- Voluntary vs Compulsory Licensing
The APG Workstream's position on these and other issues are set out in the Position Papers below, with certain policies covered in more detail in the other documents:
- APG Workstream Position Paper (February 2010)
APG Workstream Position Paper Final February 2010 
- MeTA Update paper (Dec 2007)on pilot schemes for transparency around the selection, regulation, procurement, sale and distribution of medicines in developing countries
MeTA Update Paper December 2007
- Improving Registration of Medicines in Africa (Sept 2007)
Improving Registration of Medicines in Africa September 2007
- Updating Taking Action (August 2007), the UK's strategy for tacking AIDS in the developing world
APG Response to Updating Taking Action
- Health is Global (March 2007) - proposals for a UK government-wide strategy from the Department of Health